SCHEMBL2554418

SCHEMBL2554418

O=C/C=C/c1ccc(-c2ccc(Cl)cc2)o1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.50
MEN1 O00255 5/20 0.50
MITF O75030 1/20 0.50
ALDH1A1 P00352 9/20 0.49
KDM4E B2RXH2 7/20 0.49
MAPT P10636 6/20 0.49
LMNA P02545 4/20 0.49
HPGD P15428 4/20 0.49
NPSR1 Q6W5P4 3/20 0.49
POLB P06746 2/20 0.49
HTT P42858 2/20 0.49
HSP90AA1 P07900 1/20 0.49
ALOX12 P18054 1/20 0.49
MC4R P32245 1/20 0.49
PPP1CA P62136 1/20 0.49
PRMT5 O14744 1/20 0.48
WDR77 Q9BQA1 1/20 0.48
SIRT2 Q8IXJ6 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2554420 1.00 KMT2A (0.50) KMT2AMEN1MITFALDH1A1KDM4E
SCHEMBL8806045 0.82 ALDH1A1 (0.57) KMT2AMEN1ALDH1A1KDM4EMAPT
SCHEMBL1143469 0.82 KDM4E (0.67) KMT2AMEN1MITFALDH1A1KDM4E
SCHEMBL2559940 0.79 KDM4E (0.53) KMT2AMEN1ALDH1A1KDM4EMAPT
SCHEMBL2559939 0.79 KDM4E (0.53) KMT2AMEN1ALDH1A1KDM4EMAPT
SCHEMBL6545574 0.77 ALDH1A1 (0.52) KMT2AMEN1MITFALDH1A1KDM4E
SCHEMBL3500178 0.77 ALDH1A1 (0.55) KMT2AMEN1MITFALDH1A1KDM4E
SCHEMBL7055751 0.77 ALDH1A1 (0.52) KMT2AMEN1MITFALDH1A1KDM4E
SCHEMBL3500182 0.77 ALDH1A1 (0.55) KMT2AMEN1MITFALDH1A1KDM4E
Hydrochloric Acid SCHEMBL7055755 0.76 ALDH1A1 (0.54) KMT2AMEN1MITFALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
US-11225655-B2 Bi-functional complexes and methods for making and using such complexes NUEVOLUTION A/S (DK) 2022-01-18 US disclosed
EP-3540059-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES Nuevolution A/S (DK) 2019-09-18 EP disclosed
EP-2558577-B1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION AS (DK) 2018-12-12 EP disclosed
US-20130281324-A1 BI-FUNCTINAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2013-10-24 US disclosed
US-8466291-B2 1,5-dideoxy-1,5-imino-D-glucitol compounds ACADEMIA SINICA (TW) 2013-06-18 US disclosed
US-8466291-B2 1,5-dideoxy-1,5-imino-D-glucitol compounds ACADEMIA SINICA (TW) 2013-06-18 US disclosed
EP-2558577-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES Nuevolution A/S (DK) 2013-02-20 EP disclosed
WO-2011127933-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2011-10-20 WO disclosed
US-20100113519-A1 1,5-Dideoxy-1,5-imino-D-glucitol Compounds ACADEMIA SINICA (TW) 2010-05-06 US disclosed
US-20100113519-A1 1,5-Dideoxy-1,5-imino-D-glucitol Compounds ACADEMIA SINICA (TW) 2010-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113519-A1 1,5-Dideoxy-1,5-imino-D-glucitol Compounds HEXD, GALE, GBA1 KMT2A 4450/4885MEN1 728/4885MITF 2296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.